Cancers with wild-type TP53 have different miRNA expression profiles than those with mutant TP53. In cancers with wild-type TP53, miRNAs associated with tumour suppression are enriched, promoting apoptosis and suppressing cell cycle progression. The gene discussed is TP53; the disease is neoplasm.